ACADIA Pharmaceuticals, Inc. (ACAD)
26.63
+0.34
(+1.29%)
USD |
NASDAQ |
Jan 21, 10:49
ACADIA Pharmaceuticals Cash from Investing (Quarterly): -79.35M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | -1.299M |
| ANI Pharmaceuticals, Inc. | -6.163M |
| Catalyst Pharmaceuticals, Inc. | 0.00 |
| Regeneron Pharmaceuticals, Inc. | -402.90M |
| Puma Biotechnology, Inc. | 0.506M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 74.29M |
| Cash from Financing (Quarterly) | 9.423M |
| Free Cash Flow | 98.97M |
| Free Cash Flow Per Share (Quarterly) | 0.4331 |
| Free Cash Flow to Equity (Quarterly) | 75.38M |
| Free Cash Flow to Firm (Quarterly) | 73.90M |
| Free Cash Flow Yield | 2.21% |